Ximena Navarro-Baez
Rotterdam, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Immunohistochemical Assay Variability and Human Epidermal Growth Factor Receptor 2 (HER2)-Low Breast Cancer Detection: A Laboratory Comparison in the Netherlands.
Journal: Laboratory investigation; a journal of technical methods and pathology
Published: February 25, 2026
HER2-low breast cancer in routine practice: a nationwide study of diagnostic variability across pathology laboratories.
Journal: Virchows Archiv : an international journal of pathology
Published: July 14, 2025
Decision-making in breast pathology reporting: the effect of clinical relevant thresholds.
Journal: Histopathology
Published: May 20, 2025
Reproducibility of Equivocal HER2 In Situ Hybridization Groups 3 and 4, and Comparison With HER2 mRNA Expression: The Thin Line Between Amplified and Nonamplified Breast Cancers.
Journal: Archives of pathology & laboratory medicine
Published: April 04, 2025
HER2-low across solid tumours: different incidences and definitions.
Journal: Pathology
Published: November 05, 2024
A Comparison Between Immunohistochemistry and mRNA Expression to Identify Human Epidermal Growth Factor Receptor 2-Low Breast Cancer.
Journal: Archives of pathology & laboratory medicine
Published: September 26, 2024
HER2-low and tumor infiltrating lymphocytes in triple-negative breast cancer: Are they connected?
Journal: Breast cancer research : BCR
Published: November 24, 2023
Corrigendum to "HER2-Low Breast Cancer: Incidence, Clinicopathologic Features, and Survival Outcomes From Real-World Data of a Large Nationwide Cohort" [Modern Pathology 36(4) 100087].
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: November 11, 2023
HER2-low breast cancer and response to neoadjuvant chemotherapy: a population-based cohort study.
Journal: Pathology
Published: June 20, 2023
HER2-Low Breast Cancer: Incidence, Clinicopathologic Features, and Survival Outcomes From Real-World Data of a Large Nationwide Cohort.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: November 15, 2022
Selecting patients with HER2-low breast cancer: Getting out of the tangle.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 15, 2022
Interobserver Variation in the Assessment of Immunohistochemistry Expression Levels in HER2-Negative Breast Cancer: Can We Improve the Identification of Low Levels of HER2 Expression by Adjusting the Criteria? An International Interobserver Study.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: June 29, 2022
Last Updated: 09/26/2026